Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
220.5 SEK | -3.92% | -1.78% | +4.01% |
Apr. 25 | Transcript : CellaVision AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 25 | CellaVision AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 785M 71.74M | Sales 2025 * | 895M 81.85M | Capitalization | 5.26B 481M |
---|---|---|---|---|---|
Net income 2024 * | 168M 15.36M | Net income 2025 * | 206M 18.83M | EV / Sales 2024 * | 6.55 x |
Net cash position 2024 * | 120M 10.98M | Net cash position 2025 * | 213M 19.49M | EV / Sales 2025 * | 5.64 x |
P/E ratio 2024 * |
30.4
x | P/E ratio 2025 * |
24
x | Employees | - |
Yield 2024 * |
1.12% | Yield 2025 * |
1.36% | Free-Float | 61.96% |
Latest transcript on CellaVision AB
1 day | -3.92% | ||
1 week | -1.78% | ||
Current month | -7.74% | ||
1 month | -6.77% | ||
3 months | +11.36% | ||
6 months | +72.81% | ||
Current year | +4.01% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 94-11-15 | |
Simon Ostergaard
CEO | Chief Executive Officer | 53 | 21-03-20 |
Magnus Blixt
DFI | Director of Finance/CFO | 58 | 13-05-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 59 | 94-11-15 | |
Lotta Jarleryd
BRD | Director/Board Member | 58 | 22-05-10 |
Mikael Worning
CHM | Chairman | 62 | 20-04-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 220.5 | -3.92% | 21,956 |
24-04-25 | 229.5 | -4.38% | 186,213 |
24-04-24 | 240 | +0.42% | 24,951 |
24-04-23 | 239 | +2.58% | 13,308 |
24-04-22 | 233 | +3.79% | 43,188 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.01% | 502M | |
-12.91% | 18.55B | |
-46.21% | 2.65B | |
+18.15% | 1.81B | |
-3.12% | 1.61B | |
+23.78% | 1.21B | |
-10.69% | 1.03B | |
-20.89% | 896M | |
-18.10% | 686M | |
-7.14% | 680M |
- Stock Market
- Equities
- CEVI Stock